Viracept Related Clinical Trials
Nelfinavir, a Phase I/Phase II Rectal Cancer Study [Recruiting]
Safety Of VIRACEPT; 625 mg Administered To HIV-Infected Women During Pregnancy [Completed]
A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea [Terminated]
Radical Lung Radiotherapy Plus Nelfinavir [Not yet recruiting]
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer [Recruiting]
Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer [Recruiting]
Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer [Recruiting]
Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients [Suspended]
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma [Recruiting]
Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers [Recruiting]
Nelfinavir and Lenalidomide/Dexamethasone in Patients With Progressive Multiple Myeloma That Have Failed Lenalidomide-containing Therapy [Recruiting]
Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors [Recruiting]
Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer [Recruiting]
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck [Recruiting]
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma [Recruiting]
Viracept Expanded Access Program [Completed]
The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine [Completed]
Nelfinavir and M8 Drug-Level Monitoring in HIV-1 Infection [Recruiting]
TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB [Completed]
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients [Terminated]
An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C [Completed]
A Study of Viracept in HIV-Positive Women [Completed]
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [Recruiting]
A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments [Completed]
A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive [Completed]
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme [Recruiting]
A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants [Active, not recruiting]
A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis [Completed]
A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC) [Completed]
Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants [Completed]
A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors [Completed]
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 [Completed]
A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects [Completed]
A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients [Completed]
Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [Completed]
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-Small Cell Lung Cancer [Recruiting]
Thorough QT Study of Nelfinavir [Completed]
Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC) [Recruiting]
Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients [Completed]
The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir [Completed]
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs [Active, not recruiting]
Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy [Active, not recruiting]
The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs [Completed]
Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children [Active, not recruiting]
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs [Active, not recruiting]
Stereotactic Radiation Therapy, Nelfinavir, Gemcitabine, Leucovorin, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer [Recruiting]
Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children [Active, not recruiting]
The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [Completed]
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3 [Active, not recruiting]
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma [Recruiting]
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults [Completed]
Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy [Completed]
Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen [Completed]
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection [Completed]
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection [Completed]
A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs [Completed]
A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor [Terminated]
A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients [Completed]
A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir [Completed]
A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir [Completed]
Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients [Completed]
Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir [Terminated]
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients [Completed]
A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease [Completed]
A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients [Completed]
Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission [Recruiting]
Drug Interactions Among Anti-HIV Agents [Completed]
The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children [Completed]
A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations [Completed]
A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy [Completed]
A Study of 141W94 in Combination With Other Anti-HIV Drugs [Completed]
Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir [Completed]
A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient [Completed]
Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir [Completed]
A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [Completed]
Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART) [Terminated]
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) [Active, not recruiting]
Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV [Recruiting]
A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs [Completed]
Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs [Completed]
Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) [Completed]
Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [Completed]
Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection [Completed]
Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women [Completed]
A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood
Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen [Recruiting]
When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study) [Recruiting]
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV [Recruiting]
A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment [Completed]
A Study to Determine How and Why HIV-Infected Subjects on Anti-Viral Treatment Develop Lipodystrophy [Completed]
Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy [Completed]
Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor [Recruiting]
Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection [Active, not recruiting]
A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection [Completed]
A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients [Completed]
A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment [Active, not recruiting]
A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks [Completed]
Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens [Completed]
A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly [Completed]
Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen [Completed]
Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients [Suspended]
|
